With FDA Approval, MISTR Is Set to Deliver Nationwide Access to Lenacapavir Ushering in a New Era of HIV Prevention  With today’s FDA approval of Lenacapavir as a long-acting injectable PrEP option, MISTR — the nation’s largest LGBTQ+ telehealth platform for sexual health — stands ready to deliver this breakthrough treatment to patients nationwide. “Lenacapavir is … Continued

From the Atlanta Daily World:

With FDA Approval, MISTR Is Set to Deliver Nationwide Access to Lenacapavir Ushering in a New Era of HIV Prevention  With today’s FDA approval of Lenacapavir as a long-acting injectable PrEP option, MISTR — the nation’s largest LGBTQ+ telehealth platform for sexual health — stands ready to deliver this breakthrough treatment to patients nationwide. “Lenacapavir is … Continued

The post Two Shots, No Stigma, Full Protection: Lenacapavir Is Here — and MISTR Is Ready appeared first on Atlanta Daily World.